Phoreus Biotechnology, Inc. Email Format
Biotechnology ResearchKansas, United States11-50 Employees
Phoreus Biotechnology, Inc. is a biotechnology research company based in Olathe, Kansas, focused on a proprietary delivery platform built around Branched Amphipathic Peptide Capsules (BAPC). The platform is designed to enhance the creation and delivery of vaccines, cancer therapies, alternative antibiotics, and biopesticides, with the goal of improving human, animal, plant, and environmental health. Its customers are researchers and developers seeking more effective, safer delivery systems for biologics and related therapeutics within the One Health framework. In 2021, the company announced the appointment of Steve Schram as chief executive officer and earned industry recognition for its work in animal health innovation. With a small-to-mid sized team and a focus on next-generation peptide nanocarriers, Phoreus Biotechnology positions itself within the biotechnology research sector addressing cross-species health applications.